Effect of PDE5 Inhibition on Adipose Metabolism in Humans

Phase 2 Completed NCT04684589

Summary

This is a randomized, double-blinded, placebo-controlled study of the effects of PDE5 inhibition with tadalafil on adipose tissue in obese individuals. Adipose metabolism will be measured using magnetic resonance imaging (MRI) scans and by aspirating a small amount of adipose to measure gene expression.

Thermoneutral FSF of WAT at the Level of the Umbilicus at 12 Weeks.

12 weeks · % of voxel

Thermoneutral Subcutaneous Adipose Tissue Expression of UCP1 (Normalized Expression Units) at 12 Weeks.

12 weeks · normalized expression units

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

• Ignite Pilot: Goal Setting in a Digital Weight Loss Intervention — Stanford University
• Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects — University of Pennsylvania
• Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes — The Cleveland Clinic
• Time Restricted Eating for Weight Loss Maintenance — NYU Langone Health
• Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/ — Kaiser Permanente

All trials